Less than three weeks after…
Less than three weeks after lifting a pause on the [...]
Less than three weeks after lifting a pause on the [...]
On a day when Bavarian Nordic reported booming sales and [...]
Talks between the U.K. government and the biopharma industry have [...]
Despite boasting a new owner, the Indiana manufacturing plant that [...]
U.S. pharma bounced back in Q2, and in this episode [...]
Serena Williams has a new doubles partner. The 23-time Grand [...]
Johnson & Johnson is spending part of its big U.S. [...]
CVS Health, the parent of PBM juggernaut CVS Caremark, won’t [...]
Since 2008, the FDA has approved 11 treatments for the [...]
A new campaign from AbbVie highlights the “full selves” of [...]